The Role of Diagnostics in COVID-19 “Return to Normalcy”


The COVID-19 pandemic has led to increased focus on the role of diagnostics for both clinical applications and to help build confidence in re-opening the economy. This has led to questions about different test categories, utility/limitations, and overall capacity. In this report, we attempt to address these questions and provide an assessment of when capacity can support some “return to normalcy.”

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Ahead of the Curve®

Why We Are Optimistic on COVID-19 Vaccines and Therapeutic Antibodies

Read More

Street Cred: Dog Days at the FDA

Read More

Navigating Operational Due Diligence in the Time of Covid-19

Read More